Discover 1,670 paid clinical trials in Atlanta, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Atlanta’s leading healthcare centers are recruiting participants for studies focused on developing innovative treatments for conditions such as cancer, depression, high blood pressure, and kidney disease. Whether you’re searching for paid clinical research opportunities as a healthy volunteer or trials for specific conditions, Atlanta provides a wide range of research options to meet your needs.
Filter
2
Filter results
Results: 1,670
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
for
Schizophrenia, Schizo-Affective Disorder,
Location: Decatur GA, Hialeah FL, DeSoto TX, Anaheim CA
Sponsor: BioXcel Therapeutics Inc
Sex: All
Age: 10 - 17
Code: NCT05025605
Phase 1, Recruiting
Concentrated Bone Marrow Aspirate in Revision ACL Reconstruction
for
Anterior Cruciate Ligament Injuries,
Location: Atlanta GA, New York NY
Sponsor: Hospital for Special Surgery, New York
Sex: All
Age: 18 - 55
Code: NCT06311513
Recruiting
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
for
B Acute Lymphoblastic Leukemia Associated With Down Syndrome,
Location: Atlanta GA, Greenville SC, Augusta GA, Birmingham AL,
Sponsor: Children's Oncology Group
Sex: All
Age: 6 - 39
Code: NCT05702645
Recruiting
Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients
for
Foot Injuries and Disorders, Ankle Injuries and Disorders,
Location: Atlanta GA, Johns Creek GA
Sponsor: Emory University
Sex: All
Age: 18 - 70+
Code: NCT06780202
Phase 2, Recruiting
Zesty Exercise System for Therapeutic Engagement
for
Parkinson Disease
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 40+
Code: NCT07382674
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
FOCUS for Pediatric Sickle Cell Disease and Cancer
for
Pediatric Cancer, Sickle Cell Disease, Quality of Life,
Location: Atlanta GA
Sponsor: Georgia State University
Sex: All
Age: 12 - 18
Code: NCT04075877
Recruiting
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)